Shi-Hui Wang

1-Methylhistidine attenuates early myocardial inflammation in type 3 cardiorenal syndrome through modulation of the p105/p50 NF-κB axis

Type 3 cardiorenal syndrome (CRS3) is characterized by cardiac injury or dysfunction secondary to acute kidney injury (AKI), yet the contribution of AKI-associated metabolic remodeling to early myocardial inflammation remains poorly understood. Here, paired serum and myocardial untargeted metabolomics identified 1-me...